Theravance Biopharma, Inc. (TBPH)

Sep 23, 2026 - TBPH was delisted (reason: acquired by ZYME)

17.03

0.00 (0.00%)

Inactive · Last trade price on Sep 23, 2026

Theravance Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	884	948	463	560	755	814
Market Cap Growth	26.49%	104.89%	-17.33%	-25.82%	-7.35%	-28.37%
Enterprise Value	535	660	416	477	320	1,269
Last Close Price	17.03	18.71	9.41	11.24	11.22	11.05

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.30	8.95	-	-	0.87	-
Forward PE	8.41	25.83	29.96	29.96	29.96	-
PS Ratio	8.48	8.82	7.19	9.75	14.70	14.72
PB Ratio	3.05	3.20	2.64	2.63	1.71	-2.40
P/TBV Ratio	3.05	3.20	2.64	2.63	1.71	-
P/FCF Ratio	16.45	3.98	-	-	-	-
P/OCF Ratio	16.45	3.97	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.13	6.14	6.47	8.30	6.23	22.95
EV/FCF Ratio	9.96	2.77	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.13	0.14	0.28	0.23	0.12	-1.98
Debt / FCF Ratio	0.72	0.18	-	-	-	-
Net Debt / Equity Ratio	-1.20	-0.96	-0.22	-0.25	-0.62	-1.46
Net Debt / EBITDA Ratio	-31.44	143.61	0.95	1.03	3.62	-2.13
Net Debt / FCF Ratio	-6.50	-1.19	3.25	1.81	1.47	-2.35
Asset Turnover	0.23	0.26	0.18	0.12	0.11	0.13
Quick Ratio	13.26	10.73	4.89	4.84	11.99	3.20
Current Ratio	13.54	10.93	5.02	5.39	12.31	4.26
Return on Equity (ROE)	20.91%	44.84%	-29.04%	-16.86%	-179.84%	-
Return on Assets (ROA)	1.33%	-0.54%	-7.21%	-6.78%	-10.07%	-35.20%
Return on Invested Capital (ROIC)	-	-3.66%	-28.60%	-32.89%	-32.78%	-71.83%
Return on Capital Employed (ROCE)	2.20%	-0.80%	-13.20%	-15.00%	-13.70%	-75.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	6.09%	11.17%	-12.19%	-9.86%	115.58%	-24.49%
FCF Yield	6.08%	25.16%	-2.56%	-5.27%	-24.86%	-25.94%
Buyback Yield / Dilution	-3.94%	-5.45%	11.67%	24.85%	-5.95%	-11.41%

SEC Filings: 10-K · 10-Q